Skip to content
Activity & longevityEvidence review3 min read

Exercise may improve thinking test scores in Alzheimer disease, but trials are few and small

MoveVitals Editorial Collective · Study published · Reading updated

Original paper:Effects of physical activity and exercise on the cognitive function of patients with Alzheimer disease: a meta-analysis. · BMC geriatrics · 2019 · Original paper ↗

Key takeaway

Pooling 13 randomized trials with 673 people with Alzheimer disease, exercise groups improved more than controls on the MMSE cognition score (SMD = 1.12, CI 0.66 to 1.59). The trials were few and varied, and the abstract does not give heterogeneity, so the size of the benefit and the best exercise dose remain uncertain.

Study design

Evidence review

Reading basis

Published abstract

Reading focus

Design & applicability

The research question

Alzheimer disease is the most common cause of dementia and imposes a heavy burden on patients and health systems, and exercise is seen as a practical protective option. The authors asked whether physical activity improves cognition in older adults with Alzheimer disease and whether the amount of exercise changes the effect.

Who and how

Meta-analysis of randomized controlled trials. The authors searched PubMed, Cochrane Library, Embase, Wanfang Data and China National Knowledge Infrastructure for studies published up to November 1st 2018. A random-effects model was used because studies differed, analyses were run in Stata 14.0, and subgroup analyses looked for dose-response effects. Cognition was measured with the Mini-Mental State Examination (MMSE).

What it found

The authors’ reported results. Read each estimate with its population and uncertainty.

  1. 1
    13 randomized controlled trials with 673 participants diagnosed with Alzheimer disease were included.
  2. 2
    Intervention groups showed a statistically significant improvement in MMSE score compared with control groups: standardized mean difference (SMD) 1.12, confidence interval 0.66 to 1.59.
  3. 3
    Subgroup analyses suggested that different amounts of exercise produced different effects. Higher-frequency interventions did not produce a greater effect than lower-frequency ones, and the authors say the threshold remains to be settled.

Limits & uncertainty

  1. 1
    Only 13 trials and 673 participants contributed, so subgroup comparisons by exercise frequency rest on very small numbers.
  2. 2
    The authors used a random-effects model because of heterogeneity between studies, so the exercise types and patients were not uniform; the abstract does not quantify this.
  3. 3
    Results are based on one cognitive test, the MMSE, and say nothing about daily function, quality of life or long-term decline.
  4. 4
    The authors note that more rigorous randomized trials are needed. This reading is based on the abstract only.

What to take from it

People with Alzheimer disease may do somewhat better on cognitive testing after exercise programs, but the evidence comes from a small number of trials and cannot tell anyone how much exercise to do. More was not clearly better in the frequency analysis. Exercise plans for someone with dementia should be set with their clinician and caregivers.

Reading your own data

This is a clinical trial synthesis in people diagnosed with Alzheimer disease and not something to track against your own data. If you help a relative stay active, step counts and weekly active minutes on a wearable can show consistency, but they cannot show cognition or measure an MMSE-type change.

How to read this evidence

Check which designs were included, how searches and bias assessment were conducted, and the last search date. Publication date alone does not make the underlying evidence current.

Authors’ structured abstract English

The attributed English abstract is reproduced under the recorded open licence. It is source material, not a MoveVitals interpretation. The prepared analysis above separates the authors’ findings from our interpretation.

Background

Alzheimer's disease (AD), as the most common cause of dementia, brings huge economic burden for patients and social health care systems, which motivates researchers to study multiple protective factors, among which physical activity and exercise have been proven to be both effective and economically feasible.

Methods

A systematic literature search was performed for eligible studies published up to November 1st 2018 on three international databases (PubMed, Cochrane Library, and Embase) and two Chinese databases (Wanfang Data, China National Knowledge Infrastructure). All analyses were conducted using Stata 14.0. Due to heterogeneity between studies, a random-effects model was used for this meta-analysis. Meta-analysis was used to explore if physical activity and exercise can exert positive effects on cognition of elderly with AD and subgroup analyses were conducted to find out if there are dose-response effects.

Results

A total of 13 randomized controlled trials were included with a sample size of 673 subjects diagnosed with AD. Intervention groups showed a statistically significant improvement in cognition of included subjects measured by the MMSE score (SMD = 1.12 CI:0.66~1.59) compared to the control groups. Subgroup analyses showed different amounts of physical activity and exercise can generate different effects.

Conclusions

As one of few meta-analyses comparing different quantities of physical activity and exercise interventions for AD in details, our study suggests that physical activity and exercise can improve cognition of older adults with AD. While the concomitant effects on cognition functions of high frequency interventions was not greater than that of low frequency interventions, the threshold remains to be settled. However, more RCTs with rigorous study design are needed to support our findings.

Sources & attribution

Effects of physical activity and exercise on the cognitive function of patients with Alzheimer disease: a meta-analysis.

Jia RX, Liang JH, Xu Y, Wang YQ.

BMC geriatrics · 2019-07-02

DOI: 10.1186/s12877-019-1175-2 ↗PubMed · 31266451 ↗Europe PMC · Recorded licence: cc by ↗

Abstract © the original authors, reproduced under the recorded open licence. Translations support reading; use the English record to check terminology and numerical results. Our methodological interpretation is separate from the authors’ conclusions.

MoveVitals editorial interpretation · educational content · no individual clinical review recorded

Sources checked 2026-11-01

Practical guides

Read in context

·Observational meta-analysis

7,000 steps a day linked to lower risk of death, heart disease and dementia than 2,000

Compared with 2000 steps a day, 7000 steps was associated with a hazard ratio of 0.53 (95% CI 0.46 to 0.60) for all-cause mortality across 14 studies, 0.75 (0.67 to 0.85) for cardiovascular disease and 0.62 (0.53 to 0.73) for dementia; cancer incidence was not significantly different (0.94, 0.87 to 1.01). Several outcomes rest on only two to four studies, and the certainty of evidence ranged from moderate to very low.

The Lancet Public Health

In-depth explainersRead study →
·Cohort study

Brief bursts of vigorous effort in daily life linked to lower mortality in non-exercisers

Among 25,241 UK Biobank adults who reported no leisure-time exercise, a median of 3 vigorous bouts of 1 or 2 minutes a day, picked up by a wrist accelerometer, was associated with a 38% to 40% lower risk of all-cause and cancer death and a 48% to 49% lower risk of cardiovascular death than no such bouts, over an average of 6.9 years and 852 deaths. This is an observational study using one week of wrist data and an algorithm to define vigorous effort, so it cannot show that adding such bursts causes the lower risk.

Nature Medicine

In-depth explainersRead study →
·Observational meta-analysis

Steps and mortality: gains flatten near 6,000–8,000 (age 60+) and 8,000–10,000 (under 60)

Pooling 15 cohorts (47,471 adults, 3,013 deaths, median follow-up 7.1 years), the second, third and fourth quartiles of daily steps (medians 5,801, 7,842 and 10,901) had hazard ratios for death of 0.60, 0.55 and 0.47 against the lowest quartile (median 3,553). The curve flattened at about 6,000 to 8,000 steps a day for adults aged 60 and over and 8,000 to 10,000 for younger adults. The data are observational, from a single week of step counting, mostly with waist-worn research devices.

The Lancet Public Health

In-depth explainersRead study →
·Observational meta-analysis

Accelerometers on 36,383 adults: any activity, even light, linked to lower mortality

In eight pooled cohorts (36,383 adults, mean age 62.6 years, 2,149 deaths over a median 5.8 years), the most active quarter by accelerometer-measured total activity had a mortality hazard ratio of 0.27 (95% CI 0.23 to 0.32) against the least active, and the most sedentary quarter had 2.63 (1.94 to 3.56). Light activity alone showed the same pattern, with 0.38 (0.28 to 0.51) in the top quarter. These are observational associations in adults aged 40 and over from the US and western Europe, so illness-driven inactivity and confounding cannot be excluded.

BMJ

In-depth explainersRead study →
Activity & longevity →